Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients

  • Anita K. Gandhi ,

    agandhi@celgene.com

    Affiliation Department of Translational Development, Celgene Corporation, Summit, New Jersey, United States of America

    ⨯
  • Tao Shi,

    Affiliation Department of Scientific Information Systems, Celgene Corporation, San Diego, California, United States of America

    ⨯
  • Mingyu Li,

    Affiliation Department of Biostatistics and Programming, Celgene Corporation, Summit, New Jersey, United States of America

    ⨯
  • Ulf Jungnelius,

    Affiliation Clinical Research and Development, Celgene, Summit, New Jersey, United States of America

    ⨯
  • Alfredo Romano,

    Affiliation Clinical Research and Development, Celgene, Summit, New Jersey, United States of America

    ⨯
  • Josep Tabernero,

    Affiliation Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain

    ⨯
  • Salvatore Siena,

    Affiliation Ospedale Niguarda Ca' Granda, Milan, Italy

    ⨯
  • Peter H. Schafer,

    Affiliation Department of Translational Development, Celgene Corporation, Summit, New Jersey, United States of America

    ⨯
  • Rajesh Chopra

    Affiliation Department of Translational Development, Celgene Corporation, Summit, New Jersey, United States of America

    ⨯

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.